QuidelOrtho (QDEL) director John R. Chiminski receives new RSU board grants
Rhea-AI Filing Summary
QuidelOrtho Corp director John R. Chiminski reported awards of restricted stock units (RSUs) linked to common stock. On June 25, 2026, he acquired 1,109 premium RSUs, 5,547 converted RSUs, and 15,532 equity grant RSUs as compensation.
Each RSU represents one share of QuidelOrtho common stock and carries a grant price of $0.00 per unit. One set of RSUs will vest on June 25, 2027, while an additional 1,386 units vested on June 25, 2026 and 1,387 units are scheduled to vest on each of September 25, 2026, December 25, 2026 and March 25, 2027. The RSUs were received in lieu of cash fees under a deferred compensation program for non‑employee directors, with release of vested units following the director’s elected deferral schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Chiminski John R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units (Converted) | 5,547 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units (Premium) | 1,109 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units (Equity Grant) — 15,532 shares (Direct);
Restricted Stock Units (Converted) — 5,547 shares (Direct);
Restricted Stock Units (Premium) — 1,109 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
- F2. The restricted stock units will vest on June 25, 2027.
- F3. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
- F4. 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.
Key Figures
Premium RSU grant: 1,109 units
Converted RSU grant: 5,547 units
Equity grant RSUs: 15,532 units
+3 more
6 metrics
Premium RSU grant
1,109 units
Restricted Stock Units (Premium) granted on June 25, 2026
Converted RSU grant
5,547 units
Restricted Stock Units (Converted) granted on June 25, 2026
Equity grant RSUs
15,532 units
Restricted Stock Units (Equity Grant) granted on June 25, 2026
Vested tranche
1,386 units
RSUs vested on June 25, 2026
Future vesting tranches
1,387 units each
Vest on Sept 25, 2026; Dec 25, 2026; Mar 25, 2027
Vesting date for one grant
June 25, 2027
Restricted stock units scheduled to vest on this date
Key Terms
Restricted Stock Units, deferred compensation program, vest, retainer and Board of Director service-related fees
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred compensation program financial
"under a deferred compensation program applicable to participating non-employee directors."
vest financial
"The restricted stock units will vest on June 25, 2027."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What did QuidelOrtho (QDEL) director John R. Chiminski report on this Form 4?
He reported awards of restricted stock units as non-cash board compensation. On June 25, 2026, he received three RSU grants tied to QuidelOrtho common stock, all at a grant price of $0.00 per unit under a deferred compensation program.
How many restricted stock units did John R. Chiminski receive from QuidelOrtho (QDEL)?
He received 1,109 premium RSUs, 5,547 converted RSUs, and 15,532 equity grant RSUs. Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock upon vesting and release under his elected deferral schedule.
When do John R. Chiminski’s QuidelOrtho (QDEL) restricted stock units vest?
One grant of restricted stock units will vest on June 25, 2027. Separately, 1,386 units vested June 25, 2026, and 1,387 units are scheduled to vest on September 25, 2026, December 25, 2026, and March 25, 2027, respectively.
How are QuidelOrtho (QDEL) board fees being paid to John R. Chiminski in this filing?
Board fees are being paid in restricted stock units instead of cash. The RSUs were received in lieu of certain retainer and Board service-related cash payments under a deferred compensation program for participating non-employee directors.
What does each QuidelOrtho (QDEL) restricted stock unit represent for John R. Chiminski?
Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. Delivery of those shares occurs after the RSUs vest and are released according to Chiminski’s elected deferral schedule under the company’s deferred compensation program.
AI-generated analysis. How Rhea-AI works. Not financial advice.
